Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2374-4677
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers ; volume:5 ; number:1 ; day:18 ; month:4 ; year:2019 ; pages:1-8 ; date:12.2019
npj Breast cancer ; 5, Heft 1 (18.4.2019), 1-8, 12.2019
- Urheber
-
Groenendijk, Floris H.
Treece, Tina
Yoder, Erin
Baron, Paul
Beitsch, Peter
Audeh, William
Dinjens, Winand N. M.
Bernards, Rene
Whitworth, Pat
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-019-0109-7
- URN
-
urn:nbn:de:101:1-2019050406333645915641
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Groenendijk, Floris H.
- Treece, Tina
- Yoder, Erin
- Baron, Paul
- Beitsch, Peter
- Audeh, William
- Dinjens, Winand N. M.
- Bernards, Rene
- Whitworth, Pat
- SpringerLink (Online service)
Ähnliche Objekte (12)
Manmade breast cancers
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Surgery for Good Prognosis Breast Cancers
Surgery for Good Prognosis Breast Cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
Manmade breast cancers
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Surgery for Good Prognosis Breast Cancers
Surgery for Good Prognosis Breast Cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
Manmade breast cancers
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Surgery for Good Prognosis Breast Cancers
Surgery for Good Prognosis Breast Cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study